Richard and Susan Rogel are on a mission to boost innovative cancer research and develop the next generation of cancer pioneers -- and they are committing $150 million to the University of Michigan Comprehensive Cancer Center to realize that vision.
Researchers from the University of Michigan Rogel Cancer Center will attend the American Assocation for Cancer Research Annual meeting from Sunday, April 14 through Wednesday, April 18. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
As new genes are linked to breast cancer occurring in families, and as genetic testing becomes more important in directing treatment for newly diagnosed patients, a substantial number of those at the highest risk are not getting tested.
Diane Harper, M.D., MPH, M.S., professor of family medicine at Michigan Medicine, has been named physician director for Community Outreach, Engagement and Health Disparities at the University of Michigan Rogel Cancer Center. She will lead the establishment of a community outreach engagement committee to build relationships with the community and seek input from community leaders.
When PGE2 is out of balance and the body makes too much, it can lead to inflammation and to conditions such as cancer and heart disease. Other fatty acids, particularly omega-3 fatty acids, reduce the amount of omega-6 fatty acids available in a cell. This is a key system that controls how much PGE2 the cell makes
Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a lack of guidance for effectively providing care and minimizing pain.
In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.
Cancerous cells are known activate an enzyme called telomerase, causing the cells to divide ceaselessly, a hallmark of cancer. Now, University of Michigan researchers have identified a region on a protein called TPP1 that binds this enzyme, which could provide a target for anticancer drugs.
Researchers found that 1 in 7 patients undergoing lung cancer surgery became new persistent opioid users after surgery, establishing opioid dependence as a postoperative complication that is as common as others, including atrial fibrillation.
The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Comprehensive Cancer Center member Steven Katz, M.D., MPH.